COMPANY NEWS


ERIS Lifesciences Ltd
BSE Code 540596 ISIN Demat INE406M01024 Book Value (₹) 180.24 NSE Symbol ERIS Div & Yield % 0.84 Market Cap ( Cr.) 11,906.19 P/E * 34.21 EPS * 25.58 Face Value (₹) 1
* Profit to Earning Ratio
* Earning Per Share
Board of Eris Lifesciences approves acquisition of branded formulations biz of Biocon Biologics Back
(14 Mar 2024)
The Board of Eris Lifesciences at its meeting held on 14 March 2024 has approved the following:

➢ Agreement to acquire the Branded Formulations businesses of Biocon Biologics pertaining to the Indian Territory to the extent and in the manner mentioned therein.

➢ Agreement to acquire 19% equity stake in Swiss Parenterals from the Promoters of the Company.